YONGHE MED.GR.DL-0000025 Capital Reinvestment Ratio
YONGHE MED.GR.DL-0000025 capital reinvestment ratio. YONGHE MED.GR.DL-0000025 (L97) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (€495.53 Million) in capital expenditures (€18.90 Million). Check YONGHE MED.GR.DL-0000025 investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of YONGHE MED.GR.DL-0000025 (2021–2025)
Capital reinvestment ratio of YONGHE MED.GR.DL-0000025 from 2021 to 2025. This chart tracks YONGHE MED.GR.DL-0000025's Capital Reinvestment Ratio across 3 annual periods. Also explore L97 net assets growth trend to track the company's year-over-year net asset growth rate.
YONGHE MED.GR.DL-0000025 Capital Reinvestment Ratio by Year (2021–2025)
YONGHE MED.GR.DL-0000025 capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see YONGHE MED.GR.DL-0000025 (L97) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | €495.53 Million | €18.90 Million | ▼ -83.8% |
| 2024 | 0.24x | €228.62 Million | €53.76 Million | ▼ -46.1% |
| 2021 | 0.44x | €437.28 Million | €190.64 Million | — |